abstract |
The invention describes a method for producing 3- (4-piperidinyl) -2,3,4,5-tetrahydro-1,3-benzodiazepin-2 (1H) -one of formula (I) which is a structural fragment of CGRP antagonists that can be used primarily for the treatment of migraine by ingestion. |